Split Del. Justices OK Denial Of $50M Drug Approval Bonus
Delaware's Supreme Court narrowly upheld Tuesday a lower court decision that denied stockholders of the former Calistoga Pharmaceuticals a $50 million bonus payment for limited European Union approval of a new...To view the full article, register now.
Already a subscriber? Click here to view full article